- Home
- DPRO vs SRZN Comparison
DPRO vs SRZN Comparison
Compare DPRO & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPRO
- SRZN
- Stock Information
- Founded
- DPRO 1998
- SRZN 2015
- Country
- DPRO Canada
- SRZN United States
- Employees
- DPRO N/A
- SRZN N/A
- Industry
- DPRO Aerospace
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- DPRO Industrials
- SRZN Health Care
- Exchange
- DPRO Nasdaq
- SRZN Nasdaq
- Market Cap
- DPRO 81.2M
- SRZN 97.3M
- IPO Year
- DPRO N/A
- SRZN N/A
- Fundamental
- Price
- DPRO $5.17
- SRZN $11.73
- Analyst Decision
- DPRO Strong Buy
- SRZN Strong Buy
- Analyst Count
- DPRO 2
- SRZN 2
- Target Price
- DPRO $6.50
- SRZN $38.50
- AVG Volume (30 Days)
- DPRO 1.4M
- SRZN 12.2K
- Earning Date
- DPRO 11-13-2025
- SRZN 11-05-2025
- Dividend Yield
- DPRO N/A
- SRZN N/A
- EPS Growth
- DPRO N/A
- SRZN N/A
- EPS
- DPRO N/A
- SRZN N/A
- Revenue
- DPRO $5,250,872.00
- SRZN $12,621,000.00
- Revenue This Year
- DPRO $41.59
- SRZN N/A
- Revenue Next Year
- DPRO $132.11
- SRZN N/A
- P/E Ratio
- DPRO N/A
- SRZN N/A
- Revenue Growth
- DPRO 17.08
- SRZN N/A
- 52 Week Low
- DPRO $1.63
- SRZN $5.90
- 52 Week High
- DPRO $7.31
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- DPRO 57.24
- SRZN 55.86
- Support Level
- DPRO $4.99
- SRZN $11.35
- Resistance Level
- DPRO $5.40
- SRZN $11.74
- Average True Range (ATR)
- DPRO 0.32
- SRZN 0.55
- MACD
- DPRO 0.06
- SRZN -0.12
- Stochastic Oscillator
- DPRO 79.09
- SRZN 22.20
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).